Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Alteration of gallium-67 distribution in tumor-bearing mice following treatment with methotrexate: concise communication

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5401219
The effect of methotrexate (MTX) treatment upon 67Ga distribution was investigated. Tumor bearing mice were injected with 67Ga citrate at varying time intervals following MTX treatment administered either as a single dose or in multiple doses. Altered 67Ga distribution was observed following MTX therapy, the general pattern showing decreased levels in blood and increased uptake in bone. MTX therapy decreased 67Ga uptake in liver, tumor, and muscle. The effects of MTX are related to the dose and time interval between the administrations of MTX and 67Ga. The serum of MTX-treated mice had lower unsaturated iron-binding capacities and higher levels of unbound 67Ga. Serum iron and iron binding in rats determined 20 hr after MTX therapy showed significantly higher levels of serum iron and lower levels of 67Ga in blood, and the percent transferrin saturation was approximately 95%. These observations suggest that MTX inhibition of erythropoiesis elevates serum iron levels and decreases the availability of gallium-binding sites in serum, resulting in altered 67Ga tissue distribution.
Research Organization:
Bowman Gray School of Medicine, Winston-Salem, North Carolina
OSTI ID:
5401219
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 22:12; ISSN JNMEA
Country of Publication:
United States
Language:
English